Biolife Solutions (BLFS) Share-based Compensation (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Share-based Compensation data on file, last reported at $4.8 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $4.8 million, up 15.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.6 million (down 18.16% YoY), and the FY2025 annual result was $23.0 million, down 25.64% from the prior year.
• Share-based Compensation slipped to $4.8 million in Q1 2026 per BLFS's latest filing, from $7.1 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $10.7 million in Q4 2024 and troughed at $1.2 million in Q2 2022.
• A 5-year average of $6.6 million and a median of $6.3 million in 2022 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation surged 19900.0% in 2022, then sank 41.55% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $7.7 million in 2022, then advanced by 29.3% to $9.9 million in 2023, then grew by 7.91% to $10.7 million in 2024, then slumped by 33.81% to $7.1 million in 2025, then sank by 32.09% to $4.8 million in 2026.
• Business Quant data shows BLFS's Share-based Compensation at $4.8 million in Q1 2026, $7.1 million in Q4 2025, and $5.9 million in Q3 2025.